Watson David O.'s Form 4 filing
Apellis Pharmaceuticals, Inc. (APLS) · filed Mar 6, 2025
- Accession no.
- 0000950170-25-034908
- Filed
- Mar 6, 2025
- Trade date
- Mar 4-5, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $139.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Watson David O.CIK 0001657719 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Common Stock | GGiftDisposed | −6,667 | $0.00 | $0 | 0 | Indirect | |
| Mar 4, 2025 | Common Stock | GGiftAcquired | +6,667 | $0.00 | $0 | 10,000 | Indirect | |
| Mar 5, 2025 | Common Stock | SSaleDisposed | −5,569 | $25.10 | −$139,781.9 | 138,730 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.